The Company announced the appointment of Stacy R. Lindborg, Ph.D. as President and CEO, effective May 13, 2024. Dr. Lindborg has served on IMUNON’s board of directors since 2021 and was most recently Co-CEO of BrainStorm Cell Therapeutics, where she remains a director.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMNN:
- IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
- Is IMNN a Buy, Before Earnings?
- Imunon Appoints Stacy R. Lindborg as New President and CEO
- Imunon appoints Lindborg as President, CEO
- IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024